Top Stocks For 2017


You may already know that mutual funds are vehicles that invest pools of cash contributed by investors who purchase shares of the fund. What you may not know, and what your financial adviser may never have taken the time to explain to you, are some of the fundamental aspects of a mutual fund that help to define it and differentiate it from its competitors.

See Also: Kiplinger’s Mutual Fund Finder

It is worth the effort to educate yourself about mutual funds; they are one of the most prevalent investment vehicles in the United States. According to the Investment Company Institute’s 2015 Investment Company Fact Book, mutual funds held $15.9 trillion in total net assets at the end of 2014, and 43.3% of all U.S. households were invested in them.


In fact, if you participate in your company’s retirement plan, such as a 401(k) or 403(b) plan, even if you don’t know what a mutual fund is, you likely own at least one. For this reason, it pays for every investor to know the basics of this important investment vehicle. Before you invest in a mutual fund, you should be able to answer the following seven questions about it.

Top Stocks For 2017: The NeutriSci International (NU)

Advisors’ Opinion:

  • [By Matthew Briar]

    Indeed, it’s also garnered interest from business partners. In November, Lexaria Bioscience and NeutriSci International Inc (CVE:NU) jointly announced they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line. In January, the duo announced it had finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

  • [By Matthew Briar]

    Last week — to the day, in fact — Lexaria Bioscience Corp (OTCMKTS:LXRP) announced it was teaming up with neutraceutical company NeutriSci International Inc (CVE:NU) to create a new kind of health supplement that gave consumers the ability to tap into the benefits of hemp. We hailed it as the shape of things to come. What we didn’t know, however, was how quickly those things would take shape. Just this morning the company told LXRP shareholders it was already forging another such symbiotic relationship…. this one with Hempco Food and Fiber Inc (CVE:HEMP).


    Simply put, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.

    It’s not widely recognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.


    Lexaria Bioscience changes this. In short, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity. Hemp, and hemp oil to be exact, can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.


    The future for Lexaria Bioscience is partnerships… licensing its science and know-how to companies with existing product lines and distribution networks that can easily inject hemp

  • [By Matthew Briar]

    What do you get when you cross a science that drastically improves the absorption of cannabidiol (the healthy component of cannabis) with pterostilbene (an antioxidant) tablet? It’s not a joke in search of a punch line. It’s going to be the health supplement millions of consumers have been waiting for, brought to them by a joint venture between NeutriSci International Inc (CVE:NU) and Lexaria Bioscience Corp (OTCMKTS:LXRP). The two companies announced this morning they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line.


    Lexaria has developed and patented a technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity.

    Just to be clear, hemp and marijuana are not the same thing. Hemp doesn’t have any tetrahydrocannabinol (or THC) in it, which is the key driver of its psychoactive — the ‘high’ — response. Hemp, and hemp oil to be exact, does have cannabidiol in it though, and for those who’ve been following the saga of medical marijuana and cannabis, they’ll know cannabidiol can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.


    NeutriSci International is Canadian corporation that specializes in the marketing, development and distribution of proprietary nutraceuticals. It’s got a rather wide array of products in its portfolio, but the one of immediate interest is its pterostilbene, as it fits best with the hemp-absorption technology Lexaria Bioscience brings to the table.

    Pterostilbene (found in blueberries, by the way) is o

  • [By Bryan Murphy]

    In the grand scheme of things it shouldn’t be surprising, though odds are good at least a few people are surprised at how quickly it happened. That is, health supplement and healthy-foods brand name NeutriSci International Inc (CVE:NU) and the developer of a cannabis-infusion technology — a means of packing more CBD into hemp oil — called Lexaria Bioscience Corp (OTCMKTS:LXRP) have finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.


    The benefits of cannabidiol, found in hemp and marijuana, are relatively well understood by the market at this point. Cannabidiol can do a human body a lot of good, like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more. Pterostilbene is the lesser-known of the two components of the new tablet, but no less impressive and no less beneficial. Pterostilbene is known to combat high cholesterol, high blood pressure, and oxidative stress. Combining the two is a real one-two punch for the health-conscious.

    That’s what made November’s news so exciting… NeutriSci International has an established name and marketing channel, while Lexaria Bioscience has the science that makes hemp oil far more functional. Indeed, to fully appreciate the upside for LXRP, one has to embrace Lexaria’s science and why it matters.


    The bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short,

Top Stocks For 2017: Qualstar Corporation(QBAK)


Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggestedshorting small cap data storage systems stock Qualstar Corporation (NASDAQ: QBAK):

    Quelstar is essentially a mirror image of Pixelworks. That is, it’s not just the bearish undertow we want to tap into here. It’s the failure of QBAK to follow-through on today’s effort to break above the 100-day moving average line with today’s early effort. The market dared the bulls to play their hand, and as it turns out, they were bluffing. The sheer scope of the reversal bar in the meantime today confirms the downtrend.

Top Stocks For 2017: Unilever PLC(UL)

Advisors’ Opinion:

  • [By Paul Ausick]

    Unilever PLC (NYSE: UL) dropped about 1.4% on Friday to post a new 52-week low of $38.58 after closing at $39.11 on Thursday. The stock’s 52-week high is $48.97. Volume was more than double the daily average of around 1.5 million shares. The consumer products company had no specific news on Friday.

  • [By Lisa Levin]

    Non-cyclical consumer goods & services shares climbed by 1.13 percent in trading on Friday. Meanwhile, top gainers in the sector included Unilever plc (ADR) (NYSE: UL), and Grand Canyon Education Inc (NASDAQ: LOPE).

  • [By Ben Levisohn]

    Kraft Heinz (KHC) soared to the top of the S&P 500 today after making a $143 billion bid for Unilever (UL).

    Getty Images

    Kraft Heinzgained 11% to $96.65 today, while the S&P 500 rose 0.2% to 2,351.16. Unilever jumped 14% to $48.53.